Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV

The use of antiretrovirals (ARVs) as oral, topical, or long-acting pre-exposure prophylaxis (PrEP) has emerged as a promising strategy for HIV prevention. Clinical trials testing Truvada(®) [tenofovir disoproxil fumarate (TDF)/tenofovir (TFV) and emtricitabine (FTC)] as oral or topical PrEP in Afric...

Descripción completa

Detalles Bibliográficos
Autores principales: Zondo, Nomusa M., Sobia, Parveen, Sivro, Aida, Ngcapu, Sinaye, Ramsuran, Veron, Archary, Derseree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557974/
https://www.ncbi.nlm.nih.gov/pubmed/36246609
http://dx.doi.org/10.3389/fgene.2022.940661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557974/
https://www.ncbi.nlm.nih.gov/pubmed/36246609
http://dx.doi.org/10.3389/fgene.2022.940661

Ejemplares similares